Analysis from the Tufts Center for the Study of Drug Development to Assess the Financial Benefits from Translational Pharmaceutics®: A Platform for Accelerating Product Development

10:55 - 11:30

  • Discover the difference between Translational Pharmaceutics and traditional approaches to drug development. 
  • Realise the multi-million dollar benefits of Translational Pharmaceutics, as demonstrated in the Tufts CSDD study.
  • Learn how much time and budget you could save on your drug development timeline.
  • Uncover the findings of the Tufts CSDD study including a review of the methodology, results and key conclusions.
  • Hear from real case studies which demonstrate how Translational Pharmaceutics can be utilised during drug development.

Please note that this will be a remote presentation

Andrew Lewis, Vice President, Pharmaceutical Sciences, Quotient Sciences